Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Riken Vitamin Co Ltd Raises Consolidated Mid-year Outlook for FY 2014


Sunday, 20 Oct 2013 10:00pm EDT 

Riken Vitamin Co Ltd announced that it has raised its consolidated mid-year outlook for revenue from JPY 41,000 million to JPY 41,080 million, operating profit from JPY 2,200 million to JPY 2,370 million, ordinary profit from JPY 2,300 million to JPY 2,520 million, net profit from JPY 1,200 million to JPY 1,630 million and earning per share from JPY 54.27 to JPY 73.71, for the fiscal year ending March 2014. The Company raised the outlook due to the increased sales, among others. 

Company Quote

4040.0
210.0 +5.48%
26 Dec 2014